Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0YZHLK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
daratumumab-I-14-0.29
|
|||||
| Synonyms |
Daratumumab-I-14-0.29
Click to Show/Hide
|
|||||
| Organization |
Kleo Pharmaceuticals, Inc.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
0.29
|
|||||
| Structure |
|
|||||
| Antibody Name |
Daratumumab
|
Antibody Info | ||||
| Antigen Name |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (CD38)
|
Antigen Info | ||||
| Payload Name |
Cetuximab-I-45-0.7 payload
|
Payload Info | ||||
| Linker Name |
Daratumumab-I-14-0.29 linker
|
Linker Info | ||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
I-14
|
|||||